Funding opportunities
319 live opportunities from Grants.gov, NIH, NSF, and more.
Mathematics & Statistics× remove
- Borrelia burgdorferi genotypic diversity, pathogenesis, and host cellular responsesNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $715,313activenih
- Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer PatientsNational Cancer InstitutePAR-25-167 closes 5/31/2031up to $663,998activenih
- Impact of Effective Chemoprevention in Early Childhood on the Development of Naturally Acquired Immunity to Malaria.National Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $810,125activenih
- Immune checkpoint inhibitors in patients with Rheumatoid Arthritis and Melanoma: a study using real world dataNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-24-176 closes 5/31/2031up to $129,330activenih
- Answering important questions in HIV with mismeasured clinical endpointsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $780,474activenih
- A novel eNAMPT-neutralizing mAb to reduce antimicrobial resistance following hospital- and ventilator-associated bacterial pneumoniaNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $861,088activenih
- Reprogramming Virus-Primed Immunity for Targeted Immunotherapy of Ovarian CancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $696,221activenih
- Communication and Hospice Online with Optimal Support and Engagement (CHOOSE)National Cancer InstitutePAR-25-167 closes 5/31/2031up to $656,181activenih
- Neurocognitive mechanisms of the negative retrieval bias in depressionNational Institute of Mental HealthPA-24-176 closes 5/31/2031up to $179,096activenih
- Research on End-user Acceptability.and Long-term Impacts of HIV Cure Strategies (REALISE)National Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $777,756activenih
- Modulating the Action of Cylindrical Proteases to Eliminate Neisseria Gonorrhea and Chlamydia Trachomatis InfectionsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $799,619activenih
- TARGETING VAV1 SCAFFOLDING AND ENZYMATIC FUNCTIONS IN MULTIPLE SCLEROSIS VIA BRAIN-PENETRANT MOLECULAR GLUE DEGRADERSNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $798,854activenih
- Impaired Cerebral Autoregulation, Neurologic Injury, and Modifiable Clinical Factors in Pediatric ECMO: An analysis of prospectively collected, multicenter, high-frequency physiologic dataNational Institute of Neurological Disorders and StrokePA-24-185 closes 5/31/2031up to $219,483activenih
- Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapyNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 5/31/2031up to $713,834activenih
- Quantitative scalp and intracranial EEG in surgical planningNational Institute of Neurological Disorders and StrokePA-25-301 closes 5/31/2031up to $646,295activenih
- The Role of the Intestinal Microbiota in Sepsis MortalityNational Institute of Allergy and Infectious DiseasesPA-24-182 closes 5/31/2031up to $192,330activenih
- Impact of prenatal opioid exposure on neurobehavioral developmentNational Institute on Drug AbusePA-24-176 closes 5/31/2031up to $191,070activenih
- Mechanisms of Action and Resistance of FDA-approved Antifungals Targeting Fungal beta-(1,3)-Glucan SynthaseNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $824,451activenih
- Quantitative 3D imaging of cerebral blood flow during strokeNational Institute of Neurological Disorders and StrokePA-25-301 closes 5/31/2031up to $541,700activenih
- Linear diribonucleotides regulation of bacterial physiology and infectionsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $571,412activenih
- Role of cellular physical interactions in pancreatic cancer progressionNational Cancer InstitutePA-25-301 closes 5/31/2031up to $567,264activenih
- Optimization of a novel and effective antiviral agent targeting Zika NS4BNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $627,625activenih
- Computational prediction of anti-cancer drug metabolizing enzymes in the human microbiomeNational Cancer InstitutePA-25-301 closes 5/31/2031up to $747,790activenih
- Understanding inflammatory cell death as a driver of VEXAS pathogenesisNational Cancer InstitutePA-24-182 closes 5/31/2031up to $294,451activenih
- Identifying Biobehavioral Predictors and Targeting Mechanisms of Intervention in Adolescent Posttraumatic Stress DisorderNational Institute of Mental HealthPA-24-184 closes 5/31/2031up to $206,547activenih